This topic contains a solution. Click here to go to the answer

Author Question: If regulators were to ensure that monopolistically competitive firms follow a marginal cost-pricing ... (Read 48 times)

altibaby

  • Hero Member
  • *****
  • Posts: 562
If regulators were to ensure that monopolistically competitive firms follow a marginal cost-pricing rule:
 a. new firms would be likely to enter the market.
 b. the most efficient firms would not likely be affected.
  c. all firms would experience losses.
 d. firms would operate at the most efficient scale.

Question 2

The farmer's association is a type of government with unlimited jurisdiction.
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Chou

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

c

Answer to Question 2

F




altibaby

  • Member
  • Posts: 562
Reply 2 on: Jun 30, 2018
YES! Correct, THANKS for helping me on my review


FergA

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library